Three steps to better toric surgery

Article

New at congress, Zeiss Toric Solution is a combination of tools to allow physicians to implant and align toric lenses faster and easier.

New at congress, Zeiss Toric Solution is a combination of tools to allow physicians to implant and align toric lenses faster and easier.

The combined solution is designed to provide fast and reliable toric lens surgery to astigmatic patients with increased safety through an integrated workflow that delivers improved diagnostics, the benefits of microincision and assists with accurate implantation.

“Our objective is to provide, not just boxes, but solutions to problems,” said Dr Christian Muller, managing director Acri.Tec GmbH, a Carl Zeiss Meditec company. “In the past, these treatments were more an art than a science. Our toric solution brings everything closer to science, with more predictable outcomes.” Muller highlighted three features that he believes make this possible.

The first is the calculation of Zeiss toric IOLs through Z Calc, an online calculator providing customised results with modifiable sphere and cylinder powers for excellent refractive outcomes.

The second is the advanced toric IOLs offered by Carl Zeiss Meditec: the AT TORBI, a bitoric monofocal lens; and AT LISA, a toric multifocal lens. Both have been designed for sub-2mm microincision surgery to remove the risk of surgery induced astigmatism.

Muller said the third important piece of the solution is the new video supported Z Align tool that enables surgeons to accurately position toric IOLs using an integrated eye tracking system and axis overlay on video.

According to Muller, there has been a steady stream of doctors at the Carl Zeiss Meditec stand, all registering to use the new online calculator.

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.